Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages.

Saved in:
Bibliographic Details
Title: Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages.
Authors: Lorey MB; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland.; Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland., Youssef A; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada., Äikäs L; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland., Borrelli M; Department of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada., Hermansson M; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland., Assini JM; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada., Kemppainen A; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland., Ruhanen H; Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.; Helsinki University Lipidomics Unit (HiLIPID), Helsinki Institute of Life Science (HiLIFE) and Biocenter Finland, Helsinki, Finland., Ruuth M; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland., Matikainen S; Helsinki Rheumatic Disease and Inflammation Research Group, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kovanen PT; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland., Käkelä R; Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.; Helsinki University Lipidomics Unit (HiLIPID), Helsinki Institute of Life Science (HiLIFE) and Biocenter Finland, Helsinki, Finland., Boffa MB; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada., Koschinsky ML; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.; Department of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada., Öörni K; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland.; Molecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 May 24; Vol. 10, pp. 1130162. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2297-055X
DOI:10.3389/fcvm.2023.1130162